SPONSORED CONTENT
Trademark registration service includes:
- Trademark attorney managed
- Federal trademark search
- Apply online - fast & easy
- Electronic filing of application
- You are always kept informed
By: NOVARTIS AG
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy ...
Status Alert: On Tuesday, October 29, 2019, the status for the ZOLGENSMA mark changed to REGISTERED .
On Monday, November 06, 2017, a U.S federal trademark application was filed for ZOLGENSMA by AveXis, Inc., 2275 Half Day Rd., Suite 200, Bannockburn, IL. The USPTO has assigned the ZOLGENSMA mark the serial number 87673650. The ZOLGENSMA mark has been filed in the category Pharmaceutical Products. The owner of the ZOLGENSMA mark is listed as NOVARTIS AG, CH-4002, BASEL. The correspondent for the ZOLGENSMA mark is Maury M. Tepper, III Tepper & Eyster, PLLC of 3724 BENSON DR, RALEIGH, NC 27609, UNITED STATES. If you have licensing, usage or other questions concerning the ZOLGENSMA mark, please contact the owner through the listed correspondent. The description provided for the ZOLGENSMA mark is Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy ... |
|
Word Mark: | ZOLGENSMA |
Status: | REGISTERED |
Status Date: | 10/29/2019 |
Serial Number: | 87673650 |
Filing Date: | 11/06/2017 |
Registration Number: | 5897769 |
Registration Date: | 10/29/2019 |
Goods and Services: | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression |
Type Of Mark: | Trademark |
Register Type: | Principal |
Published For Opposition Date: | 05/15/2018 |
Current Owner: | NOVARTIS AG CH-4002 BASEL 4002 SWITZERLAND |
Mark Description: | Not Available |
Mark Drawing Type: | Not Available |
Design Search: | Not Available |
Disclaimer: | Not Available |
Correspondent: | Maury M. Tepper, III Tepper & Eyster, PLLC 3724 BENSON DR RALEIGH, NC 27609 UNITED STATES |
International Class(es): | 005 |
US Class(es): | 006, 018, 044, 046, 051, 052 |
Primary Class: | Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
Class(es) Status: | Active |
First Use Anywhere: | 06/10/2019 |
First Use In Commerce: | 06/10/2019 |
Retrieve Trademark Documents |